2013 NCCN Nursing Program: Advancing Oncology Nursing™

Hollywood, FL US
March 13, 2013

The NCCN 2013 Oncology Nursing Program at the NCCN 18th Annual Conference will provide the oncology nurse with comprehensive and clinically relevant information regarding the management of patients with cancer. This program will focus on hereditary colorectal cancer, management of chemosensory dysfunction, management of adverse events in metastatic prostate cancer and metastatic breast cancer, risk assessment for VTE and thromboprophylaxis, and prevention and treatment of cancer-related infections. Oncology nurses will leave this program with information to provide the best clinical care and patient education to further improve their patients' quality of life.

Target Audience

This program is designed to meet the educational needs of oncology nurses who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

Hereditary Colorectal Cancer: The right test, right person, right time

  • Describe common genetic syndromes that increase a patient’s risk of developing colorectal cancer
  • Outline the recommended genetic testing for identifying high-risk patients
  • Provide examples of when it is appropriate to refer a patient for genetic counseling

Nutritional Impact and Management of Chemosensory Dysfunction

  • Describe the types of chemosensory dysfunction
  • Outline interventions for patient self-management of chemosensory dysfunction
  • Provide an example of one strategy for managing anorexia/cachexia related to chemosensory dysfunction

Recognition and Management of Adverse Events in Metastatic Prostate Cancer

  • Outline recent therapeutic developments for the treatment of metastatic prostate cancer
  • Describe common side effects related to the treatment of metastatic prostate cancer
  • Provide an example of one strategy for managing an adverse event related to the treatment of metastatic prostate cancer

Recent Advances in Risk Assessment for VTE and Thromboprophylaxis

  • Discuss factors that contribute to the risk of VTE and identify high-risk patients who may benefit most from thromboprophylaxis
  • Summarize the current standard of care for thromboprophylaxis in patients with cancer
  • Provide an example of a course of treatment for a patient receiving thromboprophylaxis

Recognition and Management of Adverse Events in Metastatic Breast Cancer

  • Outline recent therapeutic developments for the treatment of metastatic breast cancer
  • Describe common side effects related to the treatment of metastatic breast cancer
  • Provide an example of one strategy for managing an adverse event related to the treatment of metastatic breast cancer

Implementing Guidelines for the Prevention and Treatment of Cancer-related Infections

  • Describe the advantages of implementing clinical practice guidelines for the prevention and treatment of cancer-related infections
  • Identify one barrier to implementation of clinical practice guidelines
  • Provide one example of how to overcome a barrier to implementation of clinical practice guidelines
Additional information
Supporters: 

This activity is supported by an educational donation provided by Amgen.

This activity is supported by educational grants from Genentech; Janssen Biotech, Inc. administered by Janssen Services, LLC; Merck Sharp & Dohme Corp.; Novartis Pharmaceuticals Corporation; and Teva Pharmaceuticals.

Course summary
Available credit: 
  • 5.50 Participation
  • 5.50 Nurse
Course opens: 
03/13/2013
Course expires: 
02/28/2014
Event starts: 
03/13/2013 - 8:00am
Event ends: 
03/13/2013 - 2:55pm
Cost:
$0.00
The Westin Diplomat
3555 South Ocean Drive
Hollywood, FL 33019
United States

Christopher R. Friese, PhD, RN, AOCN, FAAN
University of Michigan Comprehensive Cancer Center

Heather Hampel, MS, CGC
The Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute

Nagi Kumar, PhD, RD, FADA
Moffitt Cancer Center

Georgia Litsas, MSN, ANP-BC, AOCNP
Dana-Farber/Brigham and Women’s Cancer Center

Brenda Shelton, MS, RN, CCRN, AOCN
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sarah Yenser Wood, RN, MSN, ANP, AOCNP
Duke Cancer Institute

Available Credit

  • 5.50 Participation
  • 5.50 Nurse

Accreditation Period

Course opens: 
03/13/2013
Course expires: 
02/28/2014

Price

Cost:
$0.00
Please login or register to take this course.